You just read:

Ascendis Pharma A/S Announces Publication of Comprehensive Results from Randomized, Active-Controlled Phase 2 Trial of Once-Weekly TransCon Growth Hormone in Pediatric Patients

News provided by

Ascendis Pharma A/S

Feb 16, 2017, 16:05 ET